Setterwalls has advised Trill Impact on the deal. Vinge advised Cinclus Pharma.Cinclus Pharma Holding AB, a biopharmaceutical company focused on the development of a novel treatment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
